High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. (Q54603571)

1 June 2018

title

High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. (English)

1 reference

1 June 2018

embryonal rhabdomyosarcoma

main subject

1 reference

Vera Paulson

1

1 reference

1 June 2018

Garvin Chandler

2

1 reference

1 June 2018

Dinesh Rakheja

3

1 reference

1 June 2018

Rene L Galindo

4

1 reference

1 June 2018

Kathleen Wilson

5

1 reference

1 June 2018

James F Amatruda

6

1 reference

1 June 2018

Scott Cameron

7

1 reference

1 June 2018

publication date

15 March 2011

1 reference

1 June 2018

Genes, Chromosomes and Cancer

published in

1 reference

1 June 2018

volume

50

1 reference

1 June 2018

page(s)

397-408

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants

cites work

1 reference

Tissue repair and stem cell renewal in carcinogenesis

21 January 2018

1 reference

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

21 January 2018

1 reference

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

Analysis of the PTCH coding region in human rhabdomyosarcoma

21 January 2018

1 reference

Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer

21 January 2018

1 reference

Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression

21 January 2018

1 reference

Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group

21 January 2018

1 reference

Molecular and cellular biology of rhabdomyosarcoma.

21 January 2018

1 reference

Medulloblastoma in mice lacking p53 and PARP: all roads lead to Gli.

21 January 2018

1 reference

A census of human cancer genes

21 January 2018

1 reference

The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas

21 January 2018

1 reference

Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study.

21 January 2018

1 reference

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

21 January 2018

1 reference

Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome

21 January 2018

1 reference

Human homolog of patched, a candidate gene for the basal cell nevus syndrome

21 January 2018

1 reference

KEGG for linking genomes to life and the environment

21 January 2018

1 reference

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

The regulation of INK4/ARF in cancer and aging

21 January 2018

1 reference

A frequent activated smoothened mutation in sporadic basal cell carcinomas

21 January 2018

1 reference

Effects of RAS on the genesis of embryonal rhabdomyosarcoma.

21 January 2018

1 reference

Tumor microenvironment and neurofibromatosis type I: connecting the GAPs

21 January 2018

1 reference

Loss of suppressor-of-fused function promotes tumorigenesis.

21 January 2018

1 reference

A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway

21 January 2018

1 reference

RAS signaling dysregulation in human embryonal Rhabdomyosarcoma

21 January 2018

1 reference

Wnt signals are targets and mediators of Gli function.

21 January 2018

1 reference

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma

21 January 2018

1 reference

Intergroup Rhabdomyosarcoma Study: update for pathologists.

21 January 2018

1 reference

Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations

21 January 2018

1 reference

Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene

21 January 2018

1 reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

The Hedgehog and Wnt signalling pathways in cancer

21 January 2018

1 reference

Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development

21 January 2018

1 reference

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

21 January 2018

1 reference

Molecular pathogenesis of rhabdomyosarcoma

21 January 2018

1 reference

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma

21 January 2018

1 reference

Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis

21 January 2018

1 reference

7 January 2021

Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study

1 reference

7 January 2021

Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes

1 reference

7 January 2021

Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, andCDKN2C) in childhood rhabdomyosarcoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20864

1 reference

1 June 2018

PubMed ID

21412928

1 reference

1 June 2018